Tag Archives: Karl J Tronstad
Research: Fitbit trackers & PROMs help monitor ME/CFS activity
Activity monitoring and patient-reported outcome measures in ME/CFS patients A small Norwegian study from the team led by Prof Olav Mella and Dr Oystein Fluge trialled wearable activity trackers and questionnaires to monitor heart rate and activity to aid pacing … Continue reading
Posted in News
Tagged activity trackers, DePaul Symptom Questionnaire, Dr Oystein Fluge, DSQ-SF, Fitbit, heart rate monitoring, Ingrid G Rekeland, Kari Sorland, Karl J Tronstad, Kine Alme, Kristin Risa, Olav Dahl, Ove Bruland, Prof Olav Mella, PROMS, SF-36, Short form 36, wearable sensor
Comments Off on Research: Fitbit trackers & PROMs help monitor ME/CFS activity
Intravenous cyclophosphamide in ME/CFS. An open-label phase II study
Intravenous Cyclophosphamide in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. An Open-Label Phase II Study by Ingrid G Rekeland, Alexander Fosså, Asgeir Lande, Irini Ktoridou-Valen, Kari Sørland, Mari Holsen, Karl J Tronstad, Kristin Risa, Kine Alme, Marte K Viken, Benedicte A Lie, Olav … Continue reading
Posted in News
Tagged Alexander Fosså, Asgeir Lande, Benedicte A Lie, cancer, chemotherapy, CycloME study, Cyclophosphamide, Ingrid G Rekeland, Irini Ktoridou-Valen, Kari Sorland, Karl J Tronstad, Kine Alme, Kristin Risa, Mari Holsen, Marte K Viken, Olav Dahl, Øystein Fluge, Prof Olav Mella
Comments Off on Intravenous cyclophosphamide in ME/CFS. An open-label phase II study
